Zevra Therapeutics (ZVRA) EBT Margin (QoQ) (2019 - 2026)
Zevra Therapeutics (ZVRA) EBT Margin (QoQ) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Zevra Therapeutics | 239.71 Mn | 39.10 Mn | 34.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8,663.00 |
| Dec 31, 2025 | 4,082.00 |
| Sep 30, 2025 | -30,090.00 |
| Jun 30, 2025 | 30,655.00 |
| Mar 31, 2025 | 16,017.00 |
| Dec 31, 2024 | 72,962.00 |
| Sep 30, 2024 | -44,794.00 |
| Jun 30, 2024 | 3,611.00 |
| Mar 31, 2024 | -33,339.00 |
| Dec 31, 2023 | 19,802.00 |
| Sep 30, 2023 | -32,073.00 |
| Jun 30, 2023 | 38,814.00 |
| Mar 31, 2023 | -27,073.00 |
| Dec 31, 2022 | 5,853.00 |
| Sep 30, 2022 | 154,456.00 |
| Dec 31, 2021 | -1,385.00 |
| Sep 30, 2021 | -14,127.00 |
| Jun 30, 2021 | 13,672.00 |
| Mar 31, 2021 | 12,027.00 |
| Dec 31, 2020 | -4,716.00 |